In this video I go over why I’m hesitant to invest in psychedelic/shroom stocks such as for profit psychedelic companies like Compass Pathways ($CMPS) and …
4 responses to “why i'm hesitant to invest in psychedelic stocks (Compass, MindMed, etc)”
I appreciate your thoughtful insight on this. Definitely a complicated thing to invest in, especially when the very notion of money seems illogical whilst partaking. My understanding is that the ultimate goal is to approach it in the same way as cannabis (legitimize medicinally first >> legalization). Maria Sabina's story is interesting. The appropriation of the mushroom ritual ended up ruining her practice and relationship with her community. I'm sure there is a relevant message in there somewhere…
Ooph. Many great points. As a seriously well intending holder of MMED among other psychedelic stocks, I would love to just rest on the good-intentions hype of it all. Alas, one has to keep an open mind. I appreciate the perspective, thanks.
00:00 why i was tempted to invest in psych stocks 01:59 why psychedelic stocks may seem like a great thing 02:46 how i first heard of the psychedelic corporate space 03:29 horizons conference panel on economic models for the expansion of psychedelics 04:00 issue #1: not a lot of BIPOC representation in psychedelic trials 05:20 for profit vs non profit meaning 05:53 issue #2: patents conflict with open science 09:29 issue #3: rapid scaling leading to a decline in therapy quality 10:47 issue #4: not everyone can afford psychedelic therapy 12:17 issue #5: decriminalization conflicts with for profit motives 15:26 issue #6: do for profits actually want you to be fully healed 16:26 closing thoughts
I appreciate your thoughtful insight on this. Definitely a complicated thing to invest in, especially when the very notion of money seems illogical whilst partaking. My understanding is that the ultimate goal is to approach it in the same way as cannabis (legitimize medicinally first >> legalization). Maria Sabina's story is interesting. The appropriation of the mushroom ritual ended up ruining her practice and relationship with her community. I'm sure there is a relevant message in there somewhere…
Ooph. Many great points. As a seriously well intending holder of MMED among other psychedelic stocks, I would love to just rest on the good-intentions hype of it all. Alas, one has to keep an open mind. I appreciate the perspective, thanks.
She is clueless on the mission of these companies. She is a hater.
00:00 why i was tempted to invest in psych stocks
01:59 why psychedelic stocks may seem like a great thing
02:46 how i first heard of the psychedelic corporate space
03:29 horizons conference panel on economic models for the expansion of psychedelics
04:00 issue #1: not a lot of BIPOC representation in psychedelic trials
05:20 for profit vs non profit meaning
05:53 issue #2: patents conflict with open science
09:29 issue #3: rapid scaling leading to a decline in therapy quality
10:47 issue #4: not everyone can afford psychedelic therapy
12:17 issue #5: decriminalization conflicts with for profit motives
15:26 issue #6: do for profits actually want you to be fully healed
16:26 closing thoughts